Crinetics Pharmaceuticals, Inc. CRNX
- PALSONIFY — Acromegaly Approved
- PALSONIFY — Carcinoid Syndrome Phase 3
Home › Targets › somatostatin receptor
somatostatin receptor (1 companies · 2 programs)
Companies with an active program directed at somatostatin receptor.